Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Journal of Child and Adolescent Psychopharmacology
|
October 25, 2022
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic)
Sarah Atkinson, Mary Bachinsky, Yaron Raiter, et al.
Forensic Science International
|
January 23, 2016
Identification of the novel synthetic cannabimimetic 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate (QMPSB) and other designer drugs in herbal incense
Karen Blakey, Sue Boyd, Sarah Atkinson, et al.
Journal of Child and Adolescent Psychopharmacology
|
April 8, 2022
Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study
Robert L Findling, Sarah Atkinson, Mary Bachinsky, et al.
CNS Spectrums
|
November 14, 2018
Safety, Tolerability, and Efficacy of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder: Results from Two Open-Label Extension Trials
Sarah Atkinson, Louise Thurman, Sara Ramaker, et al.
The International Journal of Neuropsychopharmacology
|
February 24, 2010
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study
Nizar El-Khalili, Mark Joyce, Sarah Atkinson, et al.
Journal of Child and Adolescent Psychopharmacology
|
November 30, 2017
Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder
Sarah Atkinson, Shannon Lubaczewski, Sara Ramaker, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
April 29, 2015
Participatory design of a preliminary safety checklist for general practice
Paul Bowie, Julie Ferguson, Marion MacLeod, et al.
Oncology and Therapy
|
October 13, 2025
The Management of ER-Low, HER2-Negative Breast Cancer in the United Kingdom: A Survey of Current Clinical Practice
Ka Chai Sit, Alison M Berner, Conor McCahill, et al.
Plos One
|
June 8, 2012
Diarrhoea complicating severe acute malnutrition in Kenyan children: a prospective descriptive study of risk factors and outcome
Alison Talbert, Nahashon Thuo, Japhet Karisa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Aoife M L Hunter, Sarah Atkinson, Elaine Murray, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Journal of Child and Adolescent Psychopharmacology
|
October 25, 2022
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic)
Sarah Atkinson, Mary Bachinsky, Yaron Raiter, et al.
Forensic Science International
|
January 23, 2016
Identification of the novel synthetic cannabimimetic 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate (QMPSB) and other designer drugs in herbal incense
Karen Blakey, Sue Boyd, Sarah Atkinson, et al.
Journal of Child and Adolescent Psychopharmacology
|
April 8, 2022
Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study
Robert L Findling, Sarah Atkinson, Mary Bachinsky, et al.
CNS Spectrums
|
November 14, 2018
Safety, Tolerability, and Efficacy of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder: Results from Two Open-Label Extension Trials
Sarah Atkinson, Louise Thurman, Sara Ramaker, et al.
The International Journal of Neuropsychopharmacology
|
February 24, 2010
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study
Nizar El-Khalili, Mark Joyce, Sarah Atkinson, et al.
Journal of Child and Adolescent Psychopharmacology
|
November 30, 2017
Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder
Sarah Atkinson, Shannon Lubaczewski, Sara Ramaker, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
April 29, 2015
Participatory design of a preliminary safety checklist for general practice
Paul Bowie, Julie Ferguson, Marion MacLeod, et al.
Oncology and Therapy
|
October 13, 2025
The Management of ER-Low, HER2-Negative Breast Cancer in the United Kingdom: A Survey of Current Clinical Practice
Ka Chai Sit, Alison M Berner, Conor McCahill, et al.
Plos One
|
June 8, 2012
Diarrhoea complicating severe acute malnutrition in Kenyan children: a prospective descriptive study of risk factors and outcome
Alison Talbert, Nahashon Thuo, Japhet Karisa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Aoife M L Hunter, Sarah Atkinson, Elaine Murray, et al.
Page
of 8